Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Jaffee

Showing results (61-70 of 291) with videos related to

Pageof 30
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 17, 2005
Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanismsSara Gandini, Albert B Lowenfels, Elizabeth M Jaffee, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 7, 2014
Fusion protein of mutant B7-DC and Fc enhances the antitumor immune effect of GM-CSF-secreting whole-cell vaccineMasatsugu Kojima, Satoshi Murata, Eiji Mekata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2017
Strategies for Increasing Pancreatic Tumor ImmunogenicityBurles A Johnson, Mark Yarchoan, Valerie Lee, et al.
Methods in Molecular Medicine|May 4, 2002
Cytokine gene-modified cell-based cancer vaccinesR Todd Reilly, Jean-Pascal H Machiels, Leisha A Emens, et al.
Nature Reviews. Cancer|August 25, 2017
Targeting neoantigens to augment antitumour immunityMark Yarchoan, Burles A Johnson, Eric R Lutz, et al.
Cancer Immunology Research|December 3, 2017
Report on the Third FDA-AACR Oncology Dose-Finding WorkshopLeisha A Emens, Rene Bruno, Eric H Rubin, et al.
Nature Reviews. Cancer|February 25, 2017
Targeting neoantigens to augment antitumour immunityMark Yarchoan, Burles A Johnson, Eric R Lutz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2016
Mesothelin Immunotherapy for Cancer: Ready for Prime Time?Raffit Hassan, Anish Thomas, Christine Alewine, et al.
Cancer Discovery|April 17, 2023
Converging on a Cure: The Roads to Predictive ImmunotherapyGenevieve L Stein-O'Brien, Dung T Le, Elizabeth M Jaffee, et al.
Cancer Discovery|June 1, 2026
The Rising Burden of Early-Onset Cancer: Challenges and OpportunitiesAndrea Cercek, Daniel J Zabransky, Gianluca Mauri, et al.
Pageof 30

Showing results (61-70 of 291) with videos related to

Sort By:
Pageof 30
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 17, 2005
Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanismsSara Gandini, Albert B Lowenfels, Elizabeth M Jaffee, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 7, 2014
Fusion protein of mutant B7-DC and Fc enhances the antitumor immune effect of GM-CSF-secreting whole-cell vaccineMasatsugu Kojima, Satoshi Murata, Eiji Mekata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2017
Strategies for Increasing Pancreatic Tumor ImmunogenicityBurles A Johnson, Mark Yarchoan, Valerie Lee, et al.
Methods in Molecular Medicine|May 4, 2002
Cytokine gene-modified cell-based cancer vaccinesR Todd Reilly, Jean-Pascal H Machiels, Leisha A Emens, et al.
Nature Reviews. Cancer|August 25, 2017
Targeting neoantigens to augment antitumour immunityMark Yarchoan, Burles A Johnson, Eric R Lutz, et al.
Cancer Immunology Research|December 3, 2017
Report on the Third FDA-AACR Oncology Dose-Finding WorkshopLeisha A Emens, Rene Bruno, Eric H Rubin, et al.
Nature Reviews. Cancer|February 25, 2017
Targeting neoantigens to augment antitumour immunityMark Yarchoan, Burles A Johnson, Eric R Lutz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2016
Mesothelin Immunotherapy for Cancer: Ready for Prime Time?Raffit Hassan, Anish Thomas, Christine Alewine, et al.
Cancer Discovery|April 17, 2023
Converging on a Cure: The Roads to Predictive ImmunotherapyGenevieve L Stein-O'Brien, Dung T Le, Elizabeth M Jaffee, et al.
Cancer Discovery|June 1, 2026
The Rising Burden of Early-Onset Cancer: Challenges and OpportunitiesAndrea Cercek, Daniel J Zabransky, Gianluca Mauri, et al.
Pageof 30